» Articles » PMID: 32802827

Persists in Biofilm Communities in a Smoke-exposed Ferret Model of COPD

Overview
Journal ERJ Open Res
Specialty Pulmonary Medicine
Date 2020 Aug 18
PMID 32802827
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: Non-typeable (NTHi) is a common inhabitant of the human nasopharynx and upper airways that can cause opportunistic infections of the airway mucosa including bronchopulmonary infections in patients with chronic obstructive pulmonary disease (COPD). It is clear that opportunistic infections contribute significantly to inflammatory exacerbations of COPD; however, there remains much to be learned regarding specific host and microbial determinants of persistence and/or clearance in this context.

Methods: In this study, we used a recently described ferret model for COPD, in which animals undergo chronic long-term exposure to cigarette smoke, to define host-pathogen interactions during COPD-related NTHi infections.

Results: NTHi bacteria colonised the lungs of smoke-exposed animals to a greater extent than controls, and elicited acute host inflammation and neutrophilic influx and activation, along with a significant increase in airway resistance and a decrease in inspiratory capacity consistent with inflammatory exacerbation; notably, these findings were not observed in air-exposed control animals. NTHi bacteria persisted within multicellular biofilm communities within the airway lumen, as evidenced by immunofluorescent detection of bacterial aggregates encased within a sialylated matrix as is typical of NTHi biofilms and differential bacterial gene expression consistent with the biofilm mode of growth.

Conclusions: Based on these results, we conclude that acute infection with NTHi initiates inflammatory exacerbation of COPD disease. The data also support the widely held hypothesis that NTHi bacteria persist within multicellular biofilm communities in the lungs of patients with COPD.

Citing Articles

Microbiome-host interactions in the pathogenesis of acute exacerbation of chronic obstructive pulmonary disease.

Li Y, Mao X, Shi P, Wan Z, Yang D, Ma T Front Cell Infect Microbiol. 2024; 14:1386201.

PMID: 39091676 PMC: 11291260. DOI: 10.3389/fcimb.2024.1386201.


Multimodal evaluation of drug antibacterial activity reveals cinnamaldehyde analog anti-biofilm effects against .

Asensio-Lopez J, Lazaro-Diez M, Hernandez-Cruz T, Blanco-Cabra N, Sorzabal-Bellido I, Arroyo-Urea E Biofilm. 2024; 7:100178.

PMID: 38317668 PMC: 10839773. DOI: 10.1016/j.bioflm.2024.100178.


Tobacco-enhanced biofilm formation by Porphyromonas gingivalis and other oral microbes.

Tan J, Lamont G, Scott D Mol Oral Microbiol. 2024; 39(5):270-290.

PMID: 38229003 PMC: 11250950. DOI: 10.1111/omi.12450.


Ferrets as a Mammalian Model to Study Influenza Virus-Bacteria Interactions.

Basu Thakur P, Mrotz V, Maines T, Belser J J Infect Dis. 2023; 229(2):608-615.

PMID: 37739789 PMC: 10922577. DOI: 10.1093/infdis/jiad408.


Nontypeable Haemophilus influenzae Redox Recycling of Protein Thiols Promotes Resistance to Oxidative Killing and Bacterial Survival in Biofilms in a Smoke-Related Infection Model.

Hunt B, Xu X, Gaggar A, Swords W mSphere. 2022; 7(1):e0084721.

PMID: 35044805 PMC: 8769201. DOI: 10.1128/msphere.00847-21.


References
1.
Bakaletz L, Tallan B, Hoepf T, DeMaria T, BIRCK H, Lim D . Frequency of fimbriation of nontypable Haemophilus influenzae and its ability to adhere to chinchilla and human respiratory epithelium. Infect Immun. 1988; 56(2):331-5. PMC: 259284. DOI: 10.1128/iai.56.2.331-335.1988. View

2.
Kirkham P, Barnes P . Oxidative stress in COPD. Chest. 2013; 144(1):266-273. DOI: 10.1378/chest.12-2664. View

3.
Genschmer K, Russell D, Lal C, Szul T, Bratcher P, Noerager B . Activated PMN Exosomes: Pathogenic Entities Causing Matrix Destruction and Disease in the Lung. Cell. 2019; 176(1-2):113-126.e15. PMC: 6368091. DOI: 10.1016/j.cell.2018.12.002. View

4.
Murphy T, Kirkham C, Sethi S, Lesse A . Expression of a peroxiredoxin-glutaredoxin by Haemophilus influenzae in biofilms and during human respiratory tract infection. FEMS Immunol Med Microbiol. 2005; 44(1):81-9. DOI: 10.1016/j.femsim.2004.12.008. View

5.
Ghorani V, Boskabady M, Khazdair M, Kianmeher M . Experimental animal models for COPD: a methodological review. Tob Induc Dis. 2017; 15:25. PMC: 5414171. DOI: 10.1186/s12971-017-0130-2. View